Selective Inhibition of Janus Kinase 3 Has No Impact on Infarct Size or Neurobehavioral Outcomes in Permanent Ischemic Stroke in Mice

Kelly M. DeMars(University of Florida), Eduardo Candelario‐Jalil(University of Florida)

Frontiers in Neurology

July 25, 2017

10.3389/fneur.2017.00363

Cited by 8

Related Papers

Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities

|Stroke|2022|839

Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke

|American Journal of Physiology-Cell Physiology|2018|838

Genetic Deletion or Pharmacological Inhibition of Cyclooxygenase-2 Reduces Blood-Brain Barrier Damage in Experimental Ischemic Stroke

|Frontiers in Neurology|2020|57

Receptor-interacting protein kinase 2 (RIPK2) profoundly contributes to post-stroke neuroinflammation and behavioral deficits with microglia as unique perpetrators

|Journal of Neuroinflammation|2023|31

Protective Effects of L-902,688, a Prostanoid EP4 Receptor Agonist, against Acute Blood-Brain Barrier Damage in Experimental Ischemic Stroke

|Frontiers in Neuroscience|2018|30